Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P195: The utility of fecal microRNAs in the diagnosis of inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Yi F.

Second affiliated hospital of Nanchang University, Department of Oncology, Nanchang, China

P196: Patients with ulcerative colitis (UC) and concomitant primary sclerosing cholangitis (PSC) have more subclinical endoscopic and histologic disease activity in the right colon compared to UC patients without PSCECCO '17 Barcelona
Year: 2017
Authors:

Krugliak Cleveland N.1, Rubin D.1, Meckel K.1, Tran A.1, Aelvoet A.1, Gonsalves A.1, Gaetano J.N.2, Williams K.1, Jabri B.1, Wroblewski K.3, Pekow J.*1

1University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States 2Northwestern University Feinberg School of Medicine, Chicago, United States 3University of Chicago, Department of Public Health Science, Chicago, United States

P197: Improved maternal and neonatal outcomes in a clinic dedicated to pregnant patients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Shitrit A.B.-G.*1, Koslowsky B.1, Livovsky D.M.1, Goldin E.1, Mazuz B.1, Granovsky-Grisaru S.2

1Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel 2Shaare Zedek Medical Center, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Jerusalem, Israel

P198: Dipeptidyl peptidase 4: a strong predictive marker of disease activity and treatment escalation in inflammatory bowel diseasesECCO '17 Barcelona
Year: 2017
Authors:

Pinto-Lopes P.*1,2, Afonso J.1, Macedo G.3, Magro F.1,3

1Faculty of Medicine, University of Porto, Department of Biomedicine – Pharmacology and Therapeutics Unit, Porto, Portugal 2Faculty of Medicine, University of Porto and Centro Hospitalar São João, Internal Medicine Department, Porto, Portugal 3Faculty of Medicine, University of Porto and Centro Hospitalar São João, Gastroenterology Department, Porto, Portugal

P199: PET/MR for evaluating subclinical inflammation of ulcerative colitis in remissionECCO '17 Barcelona
Year: 2017
Authors:

Wei S.C.*1, Shih I.-L.2, Lin B.-R.3, Yen R.-F.4, Chang Y.-C.2, Wong J.-M.1

1National Taiwan University Hospital and College of Medicine, Department of Internal Medicine, Taipei, Taiwan 2National Taiwan University Hospital and College of Medicine, Department of Medical Image, Taipei, Taiwan 3National Taiwan University Hospital and College of Medicine, Department of Surgery, Taipei, Taiwan 4National Taiwan University Hospital and College of Medicine, Department of Nuclear Medicine, Taipei, Taiwan

P200: Faecal calprotectin as a marker of relapse in inflammatory bowel disease – its place in the management algorithm and cost effectiveness in PolandECCO '17 Barcelona
Year: 2017
Authors:

Petryszyn P.*1, Wieckowska N.2, Trznadel A.2, Ekk-Cierniakowski P.3, Staniak A.1, Dudkowiak R.4, Piotrowski P.5

1Wroclaw Medical University, Clin Pharmacology, Wroclaw, Poland 2Wroclaw Medical University, Wroclaw, Poland 3Warsaw School of Economics, Warsawa, Poland 4Wroclaw Medical University, Gastroenterology and Hepatology, Wroclaw, Poland 5Wroclaw Medical University, Psychiatry, Wroclaw, Poland

P201: A faecal bacterial markers correlates with Calprotectin for IBD activity monitoring?ECCO '17 Barcelona
Year: 2017
Authors:

Amoedo J.*1,2, Serra-Pagès M.2, Serrano M.2, Bahí A.3, Malagόn M.3, Gilabert P.4, Guardiola J.4, Busquets D.3, Garcia-Gil J.1,2, Aldeguer X.3

1Universitat de Girona, Microbiologia, Girona, Spain 2GoodGut SL, Girona, Spain 3Institut de Investigaciό Biomèdica de Girona, Girona, Spain 4Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain

P202: Diagnosis of inflammatory bowel disease in asymptomatic subjects: disease characteristics, natural history and treatment requirementsECCO '17 Barcelona
Year: 2017
Authors:

Rodríguez-Lago I.*1, Merino O.2, Azagra I.3, Maiz A.4, Zapata E.5, Higuera R.6, Fernández-Calderόn M.7, Iriarte A.8, Arreba P.9, Carrascosa J.10, Montalvo I.11, Portillo I.12, Aguirre U.13,14, Cabriada J.L.1 IBD Study Group of the Basque–Navarre Society of Gastrointestinal Diseases, Pais Vasco-Navarra, Spain1,2,3,4,5,6,7,8,9,10,11

1Hospital de Galdakao, Gastroenterology, Galdakao, Spain 2Hospital Universitario de Cruces, Gastroenterology, Bilbao, Spain 3Hospital Universitario de Araba, Gastroenterology, Vitoria, Spain 4Hospital Donostia, Gastroenterology, Donostia, Spain 5Hospital de Mendaro, Gastroenterology, Mendaro, Spain 6Hospital de San Eloy, Gastroenterology, Bilbao, Spain 7Hospital de Mondragόn - Alto Deba, Gastroenterology, Mondragόn, Spain 8Hospital Comarcal del Bidasoa, Gastroenterology, Hondarribia, Spain 9Hospital Universitario de Basurto, Gastroenterology, Bilbao, Spain 10Hospital de Zumárraga, Gastroenterology, Zumárraga, Spain 11Onkologikoa, Gastroenterology, Donostia, Spain 12Basque Country Health Service, Colorectal cancer screening programme, Bilbao, Spain 13Hospital de Galdakao, Research Unit, Galdakao, Spain 14Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, Spain

P203: Factors associated with restless legs syndrome in patients with ulcerative colitis: a study in a tertiary care center in RomaniaECCO '17 Barcelona
Year: 2017
Authors:

Popa R.C.*1, Savin A.1, Ungureanu I.1, Gavrilescu O.1,2, Dranga M.1,2, Chiosa A.M.1, Jigaranu O.1, Popa I.1, Mihai C.1,2, Cijevschi-Prelipcean C.1,2

1Gastroenterology and Hepatology Institute, Iasi, Romania 2University Of Medicine And Pharmacy, Gr. T. Popa, Department of Gastroenterology, Iasi, Romania

P204: Lipid profile in inflammatory bowel disease under maintenance wih anti-TNF: a prospective longitudinal cohort studyECCO '17 Barcelona
Year: 2017
Authors:

Ferreiro R., Lopez-Diaz J., Lorenzo A., Dominguez-Munoz J.E., Barreiro-de Acosta M.

University Hospital Santiago de Compostela, Gastroenterology, Santiago, Spain

P205: A telemanagement system web in patients with complex inflammatory bowel disease: design and implementation of a randomized clinical trialECCO '17 Barcelona
Year: 2017
Authors:

Aguas M.*1,2, Del Hoyo J.1, Muñoz D.1, Faubel R.3,4, Barrios A.1, Navarro B.1, Bastida G.1,2, Valdivieso B.5, Nos P.1,2

1La Fe University and Politechnic Hospital, Gastroenterology, Valencia, Spain 2CIBEREHD, Networked Biomedical Research Center for Hepatic and Digestive Diseases, Valencia, Spain 3Joint Research Unit in Biomedical Engineering - eRPSS (ICT applied to healthcare process re-engineering) IIS La Fe-UPV, Valencia, Spain 4Health Services Research on Chronic Patients Network (REDISSEC), Valencia, Spain 5La Fe University and Politechnic Hospital, Telemedicine Unit, Valencia, Spain

P206: Celiac disease and inflammatory bowel disease, a rare associationECCO '17 Barcelona
Year: 2017
Authors:

Boutaleb A.*1, Saoula H.1, Aissaoui M.1, Hamidouche D.1, Aissat Y.1, Mahiou H.1, Osmane R.1, Zmiri Y.1, Mitiche A.1, Nakmouche M.1, Hamchaoui F.2

1CHU of Bab El Oued, Gastroenterology, Algiers, Algeria 2CHU of Bab El Oued, Epidemiology, Algiers, Algeria

P207: Prevalence and characteristics of Romanian patients with upper GI tract involvement in Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Dimitriu A., Ichim S., Cojocaru M., Gheorghe C., Diculescu M., Iacob R., Gheorghe L.

Clinical Institute Fundeni, Department of Digestive Diseases and Liver Transplantation, Bucharest, Romania

P208: Long term follow up of lymphocytic colitis patientsECCO '17 Barcelona
Year: 2017
Authors:

Mohamed G.*1, Crotty P.2, McNamara D.1, Breslin N.1, Ryan B.M.1

1Tallaght Hospital and Trinity College Dublin, Gastroenterology, Dublin, Ireland 2Tallaght Hospital and Trinity College Dublin, Cellular Pathology, Dublin, Ireland

P209: Long-term effectiveness and safety of vedolizumab in patients with ulcerative colitis: 5-year cumulative exposure of GEMINI 1 completers rolling into the GEMINI open-label extension studyECCO '17 Barcelona
Year: 2017
Authors:

Loftus E.V.1, Colombel J.-F.2, Feagan B.3, Vermeire S.*4, Sandborn W.5, Sands B.6, Danese S.7, D'Haens G.8, Kaser A.9, Panaccione R.10, Rubin D.11, Shafran I.12, O'Byrne S.13, Geransar P.13, James A.14, Kaviya A.15, Khalid J.M.16

1Mayo Clinic College of Medicine, Gastroenterology and Hepatology, Rochester, United States 2Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States 3Robarts Research Institute, University of Western Ontario, Robarts Clinical Trials, London, Canada 4University hospitals Leuven, Department of clinical and experimental medicine, Leuven, Belgium 5University of California - San Diego, Division of Gastroenterology, La Jolla, United States 6Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, United States 7Humanitas University, Italy, Gastrointestinal Immunopathology, Milan, Italy 8Academic Medical Centre, Dept. of Gastroenterology, Amsterdam, Netherlands 9University of Cambridge, Division of Gastroenterology and Hepatology, Cambridge, United Kingdom 10University of Calgary, Department of Medicine, Calgary, Canada 11University of Chicago Medicine Inflammatory Bowel Disease Center, Section of Gastroenterology, Hepatology, and Nutrition, Chicago, United States 12Shafran Gastroenterology Research center, Gastroenterology, Winter Park, United States 13Takeda Pharmaceuticals International AG, Global Medical Affairs, Zurich, Switzerland 14Takeda Development Centre Europe Ltd, Global Statistics and Statistical Programming, London, United Kingdom 15Takeda Development Centre Europe Ltd, Clinical Development, London, United Kingdom 16Takeda Development Centre Europe Ltd, Evidence and Value Generation, London, United Kingdom

P210: The associations of optimism, social support, and coping strategies with health-related quality of life in a cohort of patients after proctocolectomy with ileal Pouch-anal anastomosisECCO '17 Barcelona
Year: 2017
Authors:

Cohen I.*1, Benyamini Y.2, Tulchinsky H.3, Dotan I.1

1Tel Aviv Sourasky Medical Center, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Department of Gastroenterology and Liver Diseases, Tel-Aviv, Israel 2Tel Aviv University, Bob Shapell School of Social Work, Tel-Aviv, Israel 3Tel Aviv Sourasky Medical Center, affiliated to Sackler Faculty of Medicine, Proctology Unit, Department of Surgery, Tel-Aviv, Israel

P211: Differences in therapeutic approaches and outcomes in paediatric and adult onset Crohn's disease with perianal fistula: comparison of 2 multicentre fistula cohortsECCO '17 Barcelona
Year: 2017
Authors:

Sebastian S.*1,2, Black C.2, Nair M.V.1,3, Drskova T.4, Hradsky O.4, Tzivinikos C.5, Sahnan K.6, Muhammed R.7, Devadason D.8, Parmar R.S.5, Crook K.6, Akbar A.6, Thomson M.3, Pugliese D.9, Armuzzi A.9, Katsanos K.H.10, Christodoulou D.K.10, Selinger C.11, Maconi G.12, Fiorino G.13, Kopylov U.14, Bosca-Watts M.M.15, Karmiris K.16, Ellul P.17, Ben-Horin S.14, Danese S.13, Hart A.L.6

1Hull & East Yorkshire NHS Trust, Hull, United Kingdom 2Hull & East Yorkshire NHS Trust, IBD Unit, Hull, United Kingdom 3Sheffied Children's Hospitals NHS Foundation Trust, Sheffiled, United Kingdom 4Motol University Hospital, Prague, Czech Republic 5Alder Hey Children's Hospital, Liverpool, United Kingdom 6St Marks Hospital, London, United Kingdom 7Birmingham Children's Hospital, Birmingham, United Kingdom 8Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom 9Gemelli Hospital Catholic University, Rome, Italy 10University of Ioannina, Ioannina, Greece 11Leeds Teaching hospitals NHS Trust, Leeds, United Kingdom 12Louigi Sacco University Hospital, Milan, Italy 13Humanitas Research Hospital, Milan, Italy 14Sheba Medical Center, Tel-Aviv, Israel 15University Clinic Hospital, Valencia, Spain 16Venizeleio General Hospital, Crete, Greece 17Mater Dei Hospital, Msida, Malta

P212: Location and Kudo pit pattern reflect neoplastic histology of lesions detected at surveillance colonoscopy in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Iacucci M.*1,2,3, Oluseyi A.4, Panaccione R.4, Gui X.5, Urbanski S.3, Minoo P.3, Kaplan G.G.3, Novak K.3, Lowerison M.W.3, Lethebe B.C.3, Leung Y.3, Seow C.H.-T.3, Ghosh S.1

1University of Birmingham, Institute of Translational Medicine, Birmingham, United Kingdom 2University of Birmingham, UK, United Kingdom 3University of Calgary, Calgary, Canada 4University of Calgary, Gastroenterology, Calgary, Canada 5University of Calgary, Pathology, Calgary, Canada

P213: Agreement between Crohn's disease endoscopy severity scores derived from live local, delayed local video-recorded and central readingsECCO '17 Barcelona
Year: 2017
Authors:

Côté-Daigneault J.*1,2, Peerani F.2,3, Katsanos K.4, Ullman T.2, Marion J.F.2, Legnani P.2, Cohen B.L.2, Colombel J.-F.5

1Centre Hospitalier de l'Université de Montréal (CHUM), Medicine department, Montreal, Canada 2Icahn School of Medicine at Mount Sinai, Department of Medicine, New York City, United States 3University of Alberta, Zeidler Ledcor Centre, Department of Gastroenterology, Edmonton, Canada 4University Hospital of Ioannina - Greece, Department of Gastroenterology, Ioannina, Greece 5Icahn School of Medicine at Mount Sinai, Director of Helmsley IBD Center, New York City, United States

P214: What is the diagnostic accuracy of faecal calprotectin regarding endoscopic relapse in Crohn's disease patients following ileocecal resection? A tertiary single center experienceECCO '17 Barcelona
Year: 2017
Authors:

Yıldırım S., Demir N., Bozcan S., Erzin Y., Hatemi I., Celik A.F.

Istanbul University Cerrahpasa School of Medicine, Gastroenterology, Istanbul, Turkey